Alterations in nicotinic receptor alpha5 subunit gene differentially impact early and later stages of cocaine addiction: a translational study in transgenic rats and patients

Benoit C. Forget (1) , Romain Icick (1, 2, 3, 4) , Jonathan Robert (1) , Caroline Correia (1) , Marie S. Prevost (5) , Marc Gielen (4, 5) , Pierre-Jean Corringer (5) , Frank Bellivier (2, 3, 4) , Florence Vorspan (2, 3, 4) , Morgane Besson (1) , Uwe Maskos (1)

1 NISC - Neurobiologie intégrative des Systèmes cholinergiques / Integrative Neurobiology of Cholinergic Systems
2 Département de Psychiatrie et de Médecine Addictologique
3 OPTeN (UMR_S 1144 / U1144) - Optimisation thérapeutique en Neuropsychopharmacologie
4 SU - Sorbonne Université
5 Récepteurs Canaux - Channel Receptors

Cocaine addiction is a chronic and relapsing disorder with an important genetic component. Human candidate gene association studies showed that the single nucleotide polymorphism (SNP) rs16969968 in the α5 subunit (α5SNP) of nicotinic acetylcholine receptors (nAChRs), previously associated with increased tobacco dependence, was linked to a lower prevalence of cocaine use disorder (CUD). Three additional SNPs in the α5 subunit, previously shown to modify α5 mRNA levels, were also associated with CUD, suggesting an important role of the subunit in this pathology. To investigate the link between this subunit and CUD, we submitted rats knockout for the α5 subunit gene (α5KO), or carrying the α5SNP, to cocaine self-administration (SA) and showed that the acquisition of cocaine-SA was impaired in α5SNP rats while α5KO rats exhibited enhanced cocaine-induced relapse associated with altered neuronal activity in the nucleus accumbens. In addition, we observed in a human cohort of patients with CUD that the α5SNP was associated with a slower transition from first cocaine use to CUD. We also identified a novel SNP in the β4 nAChR subunit, part of the same gene cluster in the human genome and potentially altering CHRNA5 expression, associated with shorter time to relapse to cocaine use in patients. In conclusion, the α5SNP is protective against CUD by influencing early stages of cocaine exposure while CHRNA5 expression levels may represent a biomarker for the risk to relapse to cocaine use. Drugs modulating α5 containing nAChR activity may thus represent a novel therapeutic strategy against CUD.

Mots clés: cocaine use disorder; human polymorphisms; nicotinic receptors; nucleus accumbens; relapse; transgenic rats

Domaines: Neurobiologie; Psychologie et comportements

Benoit C. Forget, Romain Icick, Jonathan Robert, Caroline Correia, Marie S. Prevost, et al.. Alterations in nicotinic receptor alpha5 subunit gene differentially impact early and later stages of cocaine addiction: a translational study in transgenic rats and patients. Progress in Neurobiology, 2020, pp.101898. ⟨10.1016/j.pneurobio.2020.101898⟩. ⟨pasteur-02928473⟩